08/04/2020 – CEO of RespireRX Pharmaceuticals Inc., Tim Jones, is Featured on The Stock Day Podcast August 17, 2020j3ff1
08/04/2020 – RespireRx Pharmaceuticals Inc. Announces $2 Million Funding Commitment Allowing Option Exercise with UWM Research Foundation, Inc. and Entry into a License Agreement for GABA(A) Receptor Allosteric Neuromodulator Intellectual Property August 4, 2020j3ff1
08/03/2020 – RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer August 3, 2020j3ff1
